标普和纳斯达克内在价值 联系我们

MultiPlan Corporation MPLN NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
8/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
-56.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MultiPlan Corporation (MPLN) .

本页证实的标准:

  • VALUE (10/100, 未通过) — 分析师共识目标价暗示当前价格存在下行风险 ($10.00, 56.8%).
  • 分析师共识目标价 $10.00 (-56.8% 下行风险) — 分析师认为当前价格水平存在明显下行风险。

SharesGrow 综合评分: 8/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
8/100
SG Score
View full scorecard →
价值
10/100
Price-to-Earnings & upside
Proven by this page
未來
16/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
8/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — MPLN

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.39
EV/EBITDA0.0
每股数据
EPS (TTM)$-17.30
每股账面价值$0.00
每股营收$58.74
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$10.00 (-56.8%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2017 $207.60 $1.07B $648.13M 60.7%
2018 $11.60 $1.04B $36.22M 3.5%
2019 $3.11 $982.9M $9.71M 1%
2020 $-44.80 $937.76M $-529.63M -56.5%
2021 $6.40 $1.12B $102.08M 9.1%
2022 $-36.00 $1.08B $-572.91M -53.1%
2023 $-5.60 $961.52M $-91.7M -9.5%
2024 $-100.00 $930.62M $-1.65B -176.9%
2025 $-17.30 $965.41M $-284.28M -29.4%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言